Malik Sajad, Inamdar Shrirang, Acharya Jhankar, Goel Pranay, Ghaskadbi Saroj
Department of Zoology, Savitribai Phule Pune University, Ganeshkhind, Pune 411007, India.
Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pashan, Pune 411008, India.
Toxicol In Vitro. 2024 May;97:105802. doi: 10.1016/j.tiv.2024.105802. Epub 2024 Feb 29.
An etiology of palmitic acid (PA) induced insulin resistance (IR) is complex for which two mechanisms are proposed namely ROS induced JNK activation and lipid induced protein kinase-C (PKCε) activation. However, whether these mechanisms act alone or in consortium is not clear.
In this study, we have characterized PA induced IR in liver cells. These cells were treated with different concentrations of PA for either 8 or 16 h. Insulin responsiveness of cells treated with PA for 8 h was found to be same as that of control. However, cells treated with PA for 16 h, showed increased glucose output both in the presence and in absence of insulin only at higher concentrations, indicating development of IR. In these, both JNK and PKCε were activated in response to increased ROS and lipid accumulation, respectively. Activated JNK and PKCε phosphorylated IRS1 at Ser-307 resulting in inhibition of AKT which in turn inactivated GSK3β, leading to reduced glycogen synthase activity. Inhibition of AKT also reduced insulin suppression of hepatic gluconeogenesis by activating Forkhead box protein O1 (FOXO1) and increased expression of the gluconeogenic enzymes and their transcription factors.
Thus, our data clearly demonstrate that both these mechanisms work simultaneously and more importantly, identified a threshold of HepG2 cells, which when crossed led to the pathological state of IR in response to PA.
棕榈酸(PA)诱导胰岛素抵抗(IR)的病因复杂,目前提出了两种机制,即活性氧(ROS)诱导的JNK激活和脂质诱导的蛋白激酶C(PKCε)激活。然而,这些机制是单独起作用还是协同起作用尚不清楚。
在本研究中,我们对PA诱导的肝细胞胰岛素抵抗进行了表征。这些细胞用不同浓度的PA处理8小时或16小时。发现用PA处理8小时的细胞的胰岛素反应性与对照相同。然而,用PA处理16小时的细胞仅在较高浓度下,无论有无胰岛素存在,葡萄糖输出均增加,表明出现了胰岛素抵抗。在这些细胞中,JNK和PKCε分别因ROS增加和脂质积累而被激活。激活的JNK和PKCε使胰岛素受体底物1(IRS1)在丝氨酸307处磷酸化,导致AKT抑制,进而使糖原合酶激酶3β(GSK3β)失活,导致糖原合酶活性降低。AKT的抑制还通过激活叉头框蛋白O1(FOXO1)减少了胰岛素对肝糖异生的抑制作用,并增加了糖异生酶及其转录因子的表达。
因此,我们的数据清楚地表明这两种机制同时起作用,更重要的是,确定了HepG2细胞的一个阈值,当超过该阈值时,会导致对PA产生胰岛素抵抗的病理状态。